What is the market capitalization of MAIA Biotechnology, Inc.?

MAIA Biotechnology, Inc. (MAIA) has a market capitalization of approximately 86,945,084 USD.

How many ETFs hold MAIA?

MAIA is held by 1 ETFs tracked on Investir en Bourse.

Where can I buy MAIA in Canada?

MAIA can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

MAIA

MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc. (MAIA) is an American company in the healthcare sector, listed on AMEX. Market capitalization of 87 million USD (micro-cap).

Details

Price1.43 USD

Market cap86.95 M USD

Payout ratio0.00%

ROE-148.29%

SectorHealthcare

Websitemaiabiotech.com

Updated 2h ago

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.